These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 1356264)
21. Relation between the turnover number for vinblastine transport and for vinblastine-stimulated ATP hydrolysis by human P-glycoprotein. Ambudkar SV; Cardarelli CO; Pashinsky I; Stein WD J Biol Chem; 1997 Aug; 272(34):21160-6. PubMed ID: 9261121 [TBL] [Abstract][Full Text] [Related]
22. Rapid purification of human P-glycoprotein mutants expressed transiently in HEK 293 cells by nickel-chelate chromatography and characterization of their drug-stimulated ATPase activities. Loo TW; Clarke DM J Biol Chem; 1995 Sep; 270(37):21449-52. PubMed ID: 7665554 [TBL] [Abstract][Full Text] [Related]
23. Simple purification of highly active biotinylated P-glycoprotein: enantiomer-specific modulation of drug-stimulated ATPase activity. Julien M; Kajiji S; Kaback RH; Gros P Biochemistry; 2000 Jan; 39(1):75-85. PubMed ID: 10625481 [TBL] [Abstract][Full Text] [Related]
24. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. Horio M; Lovelace E; Pastan I; Gottesman MM Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642 [TBL] [Abstract][Full Text] [Related]
25. Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis. Eytan GD; Regev R; Assaraf YG J Biol Chem; 1996 Feb; 271(6):3172-8. PubMed ID: 8621717 [TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents. Pascaud C; Garrigos M; Orlowski S Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975 [TBL] [Abstract][Full Text] [Related]
27. Characterization and functional reconstitution of the multidrug transporter. Sharom FJ J Bioenerg Biomembr; 1995 Feb; 27(1):15-22. PubMed ID: 7629046 [TBL] [Abstract][Full Text] [Related]
28. Efficient purification and reconstitution of P-glycoprotein for functional and structural studies. Dong M; Penin F; Baggetto LG J Biol Chem; 1996 Nov; 271(46):28875-83. PubMed ID: 8910534 [TBL] [Abstract][Full Text] [Related]
29. Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. Awasthi S; Singhal SS; Srivastava SK; Zimniak P; Bajpai KK; Saxena M; Sharma R; Ziller SA; Frenkel EP; Singh SV J Clin Invest; 1994 Mar; 93(3):958-65. PubMed ID: 7907606 [TBL] [Abstract][Full Text] [Related]
30. Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Anuchapreeda S; Leechanachai P; Smith MM; Ambudkar SV; Limtrakul PN Biochem Pharmacol; 2002 Aug; 64(4):573-82. PubMed ID: 12167476 [TBL] [Abstract][Full Text] [Related]
31. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Sharom FJ; Yu X; Lu P; Liu R; Chu JW; Szabó K; Müller M; Hose CD; Monks A; Váradi A; Seprôdi J; Sarkadi B Biochem Pharmacol; 1999 Aug; 58(4):571-86. PubMed ID: 10413294 [TBL] [Abstract][Full Text] [Related]
32. Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase. Hagmann W; Nies AT; König J; Frey M; Zentgraf H; Keppler D Eur J Biochem; 1999 Oct; 265(1):281-9. PubMed ID: 10491184 [TBL] [Abstract][Full Text] [Related]
33. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein. Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255 [TBL] [Abstract][Full Text] [Related]
34. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles. Sinicrope FA; Dudeja PK; Bissonnette BM; Safa AR; Brasitus TA J Biol Chem; 1992 Dec; 267(35):24995-5002. PubMed ID: 1360981 [TBL] [Abstract][Full Text] [Related]
35. Loss of cyclosporin and azidopine binding are associated with altered ATPase activity by a mutant P-glycoprotein with deleted phe(335). Chen KG; Lacayo NJ; Durán GE; Cohen D; Sikic BI Mol Pharmacol; 2000 Apr; 57(4):769-77. PubMed ID: 10727524 [TBL] [Abstract][Full Text] [Related]
36. Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Hamada H; Tsuruo T Cancer Res; 1988 Sep; 48(17):4926-32. PubMed ID: 2900677 [TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of the multidrug transporter. Germann UA Cytotechnology; 1993; 12(1-3):33-62. PubMed ID: 7765331 [TBL] [Abstract][Full Text] [Related]
39. Reconstitution and functional studies of hamster P-glycoprotein in giant liposomes. Park S; Majd S PLoS One; 2018; 13(6):e0199279. PubMed ID: 29912971 [TBL] [Abstract][Full Text] [Related]
40. ATP and GTP as alternative energy sources for vinblastine transport by P-170 in KB-V1 plasma membrane vesicles. Lelong IH; Padmanabhan R; Lovelace E; Pastan I; Gottesman MM FEBS Lett; 1992 Jun; 304(2-3):256-60. PubMed ID: 1352260 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]